Overexpression of midkine in lung tumors induced by N-nitrosobis(2-hydroxypropyl)amine in rats and its increase with progression

Carcinogenesis

Volumn 20, Issue 3, 1999, Pages 465-469

  Sakitani, Hiroyuki ^a   Tsutsumi, Masahiro ^a   Kadomatsu, Kenji ^b   Ikematsu, Shinya ^c   Takahama, Makoto ^a   Iki, Katsumichi ^a   Tsujiuchi, Toshifumi ^a   Muramatsu, Takashi ^b   Sakuma, Sdatoshi ^c   Sakaki, Toshisuke ^a   Konishi, Yoichi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Meiji Cell Technology Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIS(2 HYDROXYPROPYL)NITROSAMINE; MESSENGER RNA; MIDKINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG ADENOMA; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

EID: 0033035377     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.3.465     Document Type: Article

References (45)

1. Aaronson, S.A. (1991) Growth factors and cancer. Science, 254, 1146-1153.
2. Cross, M. and Dexter, T.M. (1991) Growth factors in development, transformation and tumorigenesis. Cell, 64, 271-280.
3. Heldin, C.H. and Westermark, B. (1989) Growth factors as transforming proteins. Eur. J. Biochem., 184, 487-496.
4. Folkman, J. (1986) How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes Memorial Award Lecture. Cancer Res., 46, 467-473.
5. Folkman, J., Watson, K., Ingber, D. and Hanahan, D. (1995) Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature (London), 339, 58-61.
6. Tsai, J.C., Goldman, C.K. and Gillespite, G.Y. (1995) Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB and bFGF. J. Neurosurg., 82, 864-873.
7. Bernfield, M. Kokenyesi, R., Kato, M., Hinkes, M.T., Spring, J., Gallo, R.L. and Lose, E.T. (1992) Biology of syndecans. Ann. Rev. Cell. Biol., 8, 365-393.
8. Chiquet-Ehrismann, R., Mackie, E.J., Rearson, C.A. and Sakakura, T. (1986) Tenascin, an extracellular matrix protein involved in tissue interactions during fetal development and organogenesis. Cell, 47, 131-139.
9. Jalkanen, M., Elenius, K. and Rapraeger, A. (1993) Syndecan: regulator of cell morphology and growth factor action at the cell-matrix interface. Trends Glycosci. Glycotechnol., 5, 107-120.
10. Thesleff, I., Partanen, A.M. and Vainio, S. (1991) Epithelial-mesenchymal interactions in tooth morphogenesis: the roles of extracellular matrix, growth factors and cell surface receptors. J. Craniof. Genet. Dev. Biol., 11, 229-237.
11. Vainio, S., Karavanova, I., Jowett, A. and Thesleff, I. (1993) Identification of BMP-4 as a signal mediating secondary induction between epithelial and mesenchymal tissues during early tooth development. Cell, 75, 45-58.
12. Ruoslahti, E. and Yamaguchi, Y. (1991) Proteoglycans as modulators of growth activities. Cell, 64, 867-869.
13. Kadomatsu, K., Tomomura, M. and Muramatsu, T. (1988) cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cell and in mid-gestation period of mouse embryogenesis. Biochem. Biophys. Res. Commun., 151, 1312-1328.
14. Tomomura, M., Kadomatsu, K., Matsubara, S. and Muramatsu, T. (1990) A retinoic acid-responsive gene, MK, found in the teratocarcinoma system. Heterogeneity of the transcript and the nature of the translation product. J. Biol. Chem., 265, 10765-10770.
15. Kadomatsu, K., Huang, R.-P., Suganuma, T., Murata, F. and Muramatsu, T. (1990) A retinoic acid responsive gene MK found in the teratocarcinoma system is expressed in a spatially and temporally controlled manner during mouse embryogenesis. J. Cell. Biol., 110, 607-616.
16. Mitsiadis, T.A., Salmivirta, M., Muramatsu, T., Muramatsu, H., Rauvala, H., Lehtonen, E., Jalkanen, M. and Thesleff, I. (1995) Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal interactions during fetal development and organogenesis. Development, 1212, 37-51.
17. Mitsiadis, T.A., Muramatsu, T. Muramatsu, H. and Thesleff, I. (1995) Midkine (MK), a heparin-binding growth/differentiation factor, is regulated by retinoic and epithelial-mesenchymal interactions in the developing mouse tooth and affects cell proliferation and morphogenesis. J. Cell. Biol., 129, 267-281.
18. Muramatsu, H. and Muramatsu, T. (1991) Purification of recombinant midkine and examination of its biological activities: functional caparison of new heparin binding factors. Biochem. Biophys. Res. Commun., 177, 652-658.
19. Satoh, J., Muramatsu, H., Moretto, G. et al. (1993) Midkine that promotes survival of fetal human astrocytes in culture. Dev. Brain Res., 75, 201-205.
20. Michikawa, M., Kikuchi, S., Muramatsu, H., Muramatsu, T. and Kim, S.U. (1993) Retinoic acid responsive gene product, midkine, has neurotrophic functions for mouse spinal cord and dorsal root ganglion neurons in culture. J. Neurosci. Res., 35, 530-539.
21. Kojima, S., Muramatsu, H., Amanuma, H. and Muramatsu, T. (1995) Midkine is a heat and acid stable polypeptide capable of enhancing plasminogen activator activity and neurite outgrowth extension. J. Biol. Chem., 270, 9590-9596.
22. Muramatsu, H., Shirohama, H., Yonezawa, S., Maruta, H. and Muramatsu, T. (1993) Midkine, a retinoic acid-inducible growth/differentiation factor: immunohistochemical evidence for the function and distribution. Dev. Biol., 159, 392-402.
23. Nakagawara, A., Milbrandt, J., Muramatsu, T., Deuel, T., Zhao, H., Cnaan, A. and Brodeuri, G. (1995) Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res., 55, 1792-1797.
24. Garver, R.I. Jr, Radford, D.M., Donis-Keller, H., Wick, M.R. and Milner, P.G. (1994) Midkine and pleiotrophin expression in normal and malignant breast tissue. Cancer, 74, 1584-1590.
25. Garver, R.I. Jr, Chan, C.S. and Milner, P.G. (1993) Reciprocal expression of pleiotrophin and midkine in normal versus malignant lung tissues. Am. J. Resp. Cell Mol. Biol., 9, 463-466.
26. Tsutsui, J., Kadomatsu, K., Matsubara, S., Nakagawara, A., Hamanoue, M., Takao, S., Shimazu, H., Ohi, Y. and Muramatsu, T. (1993) A new family of heparin-binding growth/differentiation factor: increased midkine expression in Wilms' tumor and other human carcinomas. Cancer Res., 53, 1281-1285.
27. Mishima, K., Asai, A., Kadomatsu, K., Ino, Y., Nomura, K., Nanta, Y., Muramatsu, T. and Kirino, T. (1997) Increased expression of midkine during the progression of human astrocytomas. Neurosci. Lett., 233, 29-32.
28. O'Brien, D., Cranston, D., Fuggle, S., Bicknell, R. and Harris, A.L. (1996) The angiogenic factor midkine is expressed in bladder cancer and overexpression correlates with a poor outcome in patient with invasive cancers. Cancer Res., 56, 2515-2518.
29. Aridome, K., Tsutsui, J., Takao, S., Kadomatsu, K., Ogawa, M., Aikou, K. and Muramatsu, T. (1995) Increased midkine gene expression in human gastrointestinal cancers. Jpn. J. Cancer Res., 86, 655-661.
30. Kaname, T., Kadomatsu, K., Aridome, K., Yamashita, S., Sakamoto, K., Ogawa, M., Muramatsu, T. and Yamamura, K. (1996) The expression of truncated MK in human tumors. Biochem. Biophys. Res. Commun., 219, 256-260.
31. Miyashiro, I., Kaname, T., Nakayama, T. et al. (1996) Expression of truncated midkine in human colorectal cancers. Cancer Lett., 106, 287-291.
32. Miyashiro, I., Kaname, T., Shin, E. et al. (1997) Midkine expression in human breast cancers: Expression of truncated form. Breast Cancer Res. Treat., 43, 1-6.
33. Chen, Y., Mckenzie, K.E., Aldaz, C.M. and Sukumar, S. (1996) Midkine in the progression of rat N-nitroso-N-methylurea-induced mammary tumors. Mol. Carcinogen., 17, 112-116.
34. Choudhuri, R., Zhang, H.T., Donnini, S., Ziche, M. and Bicknell, R. (1997) An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res., 37, 1814-1819.
35. Ratovitski, E.A. and Burrow, C.R. (1997) Midkine stimulates Wilms' tumor cell proliferation via its signaling receptor. Cell Mol. Biol., 43, 425-431.
36. Ratovitski, E.A., Kotzbauer, P.T., Milbrandt, J., Lowenstein, C.J. and Burrow, C.R. (1998) Midkine induces tumor cell proliferation and binds to a high affinity signaling receptor associated with JAK tyrosine kinases. J. Biol. Chem., 273, 3654-3660.
37. Kadomatsu, K., Hagihara, M., Akhter, S., Fan, Q.W., Muramatsu, H. and Muramatsu, T. (1997) Midkine induces the transformation of NIH3T3 cells. Br. J. Cancer, 75, 359-359.
38. Nakanishi, T., Kadomatsu, K., Okamoto, T., Tomoda, Y. and Muramatsu, T. (1997) Expression of midkine and pleiotropin in ovarian tumors. Obstet. Gynecol., 90, 285-290.
39. Konishi, Y., Kondo, H., Denda, A., Takahashi, S. and Inui, S. (1978) Lung carcinomas induced by oral administration of N-bis(2-hydroxypropyl)nitrosoamine in rats. In Severi. L. (ed.) Tumors of Early Life in Man and Animals. Perugia Quadrennial International Conference of Cancer. Division of Cancer Research, Perugia University, Perugia, pp. 637-649.
40. Kitada, H., Tsutsumi, M., Tsujiuchi, T., Takahama, M., Fukuda, T., Narita, N. and Konishi, Y. (1996) Frequent mutations of Ki-ras but no mutations of Ha-ras and p53 in lung lesions induced by N-nitrosobis(2-hydroxypropyl)amine in rats. Mol. Carcinogen., 15, 276-283.
41. Nakae, D., Kobayashi, Y., Akai, H., Andoh, N., Satoh, H., Ohashi, K., Tsutsumi, M. and Konishi, Y. (1997) Involvement of 8-hydroxyguanine formation in the initiation of rat liver carcinogenesis hy low dose levels of N-nitrosodiethylamine. Cancer Res., 57, 1281-1287.
42. Folkman, J. and Shing, Y. (1992) Angiogenesis. J. Biol. Chem., 267, 10931-10934.
43. Takahama, M., Tsutsumi, M., Tsujiuchi, T. et al. (1998) Frequent expression of the vascular endothelial growth factor in human non-small cell lung cancers. Jpn. J. Clin. Oncol., 28, 176-181.
44. Sakitani, H., Tsujiuchi, T., Kobitsu, K. et al. (1998) Increased telomerase activity and absence of p53 mutation in oligo-astrocytomas induced by N-ethyl-N-nitrosourea in rats. Cancer Lett., 126, 157-164.
45. Haber, D.A., Park, S., Maheswaran, S., Englert, C., Re, G.G., Hazen-Martin, D.J., Sens, D.A. and Garvin, A.J. (1993) WTI-mediated growth suppression of Wilms' tumor cells expressing a WTI splicing variant. Science, 262, 2057-2059.